Saturday 17 October 2026
Export AHCO’s income statement to Excel — free account
AdaptHealth Corp.
AHCO Healthcare Medical Devices
In the quarter to June 2026, revenue grew 12.7%, EPS fell 1,090.0%, free cash flow fell 128.6% and total debt rose 4.30%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years; insiders bought in the last twelve months.
6.02
0.37
−5.79%
Follow AHCO
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 3 | 7 | 5 | 4 | 8 | 4 |
P/E ratio |
— | 4.81 | 0.00 | 0.00 | 21.84 | 40.29 | 0.00 | 15.61 | 0.00 |
Altman Z-Score |
— | 1.28 | 1.39 | 1.30 | 1.22 | 1.23 | 0.29 | 1.06 | 0.91 |
P/S ratio |
— | 0.00 | 0.47 | 1.84 | 1.25 | 0.87 | 0.30 | 0.39 | 0.41 |
P/FCF ratio |
— | 1.71 | 6.34 | 12.65 | 42.69 | 0.00 | 6.80 | 5.28 | 6.14 |
Altman Z″-Score (non-manufacturers) |
— | 0.06 | 0.45 | (0.11) | 1.16 | 1.16 | (0.69) | 0.83 | 0.26 |
P/Operating CF |
— | 1.68 | 14.36 | 39.16 | 30.61 | 26.77 | 6.27 | 8.47 | 7.35 |
Beneish M-Score |
— | — | (3.16) | (2.18) | (1.42) | (2.86) | (3.73) | (2.88) | (3.26) |
P/B ratio |
— | 1.14 | 0.00 | 7.02 | 1.49 | 1.20 | 0.66 | 0.81 | 0.88 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 0.00 | 1.08 | 2.48 | 2.09 | 1.60 | 0.96 | 0.97 | 0.93 |
EV/EBITDA |
— | 0.00 | 6.15 | 16.50 | 10.43 | 8.67 | 4.94 | 4.89 | 4.96 |
EV/Operating CF |
— | 3.31 | 9.50 | 13.58 | 18.66 | 12.68 | 6.38 | 5.85 | 5.00 |
EV/FCF |
— | 3.31 | 14.68 | 17.04 | 71.07 | (270.04) | 21.42 | 13.15 | 13.71 |
Quick Ratio |
0.42 | 0.58 | 1.01 | 0.64 | 1.02 | 0.89 | 0.87 | 0.91 | 0.67 |
Current Ratio |
0.42 | 0.67 | 1.18 | 0.86 | 1.34 | 1.28 | 1.21 | 1.33 | 1.02 |
Net Debt/EBITDA |
0.00 | 1.35 | 3.50 | 4.25 | 4.17 | 3.92 | 3.37 | 2.93 | 2.74 |
Debt/Assets |
0.00% | 36.42% | 73.74% | 43.27% | 41.97% | 42.00% | 48.15% | 44.70% | 40.98% |
Debt/Equity |
0.00 | 1.31 | (10.56) | 2.79 | 1.07 | 1.02 | 1.48 | 1.27 | 1.16 |
Asset Turnover |
0.00 | 1.87 | 1.16 | 0.91 | 0.70 | 0.57 | 0.66 | 0.73 | 0.74 |
Operating CF/Net income |
0.00 | 2.94 | (2.83) | (1.21) | 1.94 | 5.89 | (0.71) | 5.99 | (8.50) |
Capex/Depreciation |
— | (0.20) | (0.33) | (0.44) | (0.76) | (1.10) | (0.28) | (0.78) | (0.74) |
Interest Coverage |
— | 4.17 | 0.75 | 1.72 | 2.37 | 1.74 | (4.59) | 2.08 | 0.86 |
| 0.00% | 45.26% | (66.05%) | (133.20%) | 12.08% | 3.00% | (37.46%) | 5.94% | (4.56%) | |
| 0.00% | 12.60% | (4.66%) | (13.70%) | 4.01% | 1.21% | (13.96%) | 2.01% | (1.61%) | |
ROIC |
0.00% | 9.17% | 6.38% | 4.62% | 3.42% | 2.77% | (10.50%) | 4.74% | 1.78% |
Return on Tangible Assets |
0.00% | 139.16% | (23.47%) | (312.84%) | 24.93% | 10.30% | (111.82%) | 13.63% | (13.45%) |
Average Days of Receivables |
— | 56.04 | 54.18 | 58.32 | 53.29 | 44.13 | 44.36 | 45.67 | 41.72 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 5.23% | 10.67% | 8.34% | 6.79% | 10.93% | 10.46% | 11.02% | 11.78% |
Intangible Assets out of Total Assets |
0.00 | 0.55 | 0.49 | 0.61 | 0.71 | 0.71 | 0.63 | 0.62 | 0.61 |
Share Based Compensation of Revenue |
— | 0.26% | 2.09% | 1.74% | 1.03% | 0.75% | 0.70% | 0.46% | 0.67% |
Graham Net Nets |
— | (1.50) | (1.63) | (0.59) | (0.81) | (0.95) | (2.46) | (1.69) | (1.53) |
Graham Number |
— | 19.94 | 6.17 | 0.00 | 20.31 | 13.18 | 0.00 | 12.73 | 0.00 |
Earnings Yield |
— | 20.81% | (9.13%) | (6.94%) | 4.58% | 2.48% | (69.83%) | 6.41% | (5.42%) |
Free Cash Flow Yield |
— | 58.50% | 15.78% | 7.91% | 2.34% | (0.68%) | 14.70% | 18.93% | 16.30% |
Revenue per Share |
0.00 | 29.02 | 23.48 | 20.40 | 19.52 | 22.14 | 23.85 | 24.38 | 24.01 |
Operating CF per Share |
0.00 | 5.75 | 2.68 | 3.73 | 2.18 | 2.79 | 3.58 | 4.05 | 4.45 |
Capex per Share |
0.00 | (0.84) | (0.95) | (0.76) | (1.61) | (2.92) | (2.52) | (2.25) | (2.83) |
Free Cash Flow per Share |
0.00 | 4.91 | 1.73 | 2.97 | 0.57 | (0.13) | 1.07 | 1.80 | 1.62 |
Cash per Share |
0.00 | 2.12 | 3.41 | 1.90 | 1.18 | 0.34 | 0.57 | 0.82 | 0.79 |
Shareholders Equity per Share |
0.00 | 8.64 | (1.69) | 5.35 | 16.36 | 16.08 | 10.93 | 11.80 | 11.29 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 8.64 | (1.69) | 5.35 | 16.36 | 16.08 | 10.93 | 11.80 | 11.29 |
Free Cash Flow |
— | 58.48 | 39.09 | 155.88 | 72.37 | (17.56) | 143.20 | 241.10 | 219.38 |
Working Capital |
(0.17) | (44.89) | 27.36 | (58.80) | 170.25 | 129.09 | 112.02 | 188.80 | 16.51 |
Capital Expenditures |
— | (9.95) | (21.33) | (39.75) | (203.31) | (391.42) | (337.46) | (300.74) | (382.39) |
Net Current Asset Value |
(0.17) | (175.40) | (403.27) | (1,169.38) | (2,513.74) | (2,476.52) | (2,392.96) | (2,153.04) | (2,061.35) |
EV/EBIT |
— | 7.27 | 19.53 | 37.23 | 22.80 | 24.90 | 0.00 | 12.02 | 33.11 |
Capex to Sales |
— | 0.03 | 0.04 | 0.04 | 0.08 | 0.13 | 0.11 | 0.09 | 0.12 |
Price to Operating Income |
— | 0.00 | 8.43 | 27.63 | 13.69 | 13.63 | 0.00 | 4.83 | 14.81 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.80 | 1.01 | 0.81 | 0.67 | 0.73 | 2.46 | 0.81 | 1.01 |
Cash ROIC |
0.00% | 22.29% | 8.85% | 13.37% | 1.64% | (0.40%) | 3.86% | 6.53% | 6.45% |
Accounts Receivable Turnover |
— | 5.23 | 8.05 | 8.58 | 9.29 | 8.26 | 8.56 | 8.18 | 8.33 |
Accounts Payable Turnover |
0.00 | 6.85 | 4.68 | 5.04 | 6.56 | 6.87 | 7.06 | 6.22 | 5.32 |
Inventory Turnover |
— | 27.94 | 42.15 | 24.95 | 22.09 | 19.06 | 21.34 | 20.36 | 18.11 |
Average Days of Payables |
0.00 | 106.44 | 85.08 | 103.26 | 65.11 | 51.53 | 55.54 | 61.97 | 76.68 |
Days of Inventory on Hand |
— | 9.55 | 10.96 | 23.88 | 22.37 | 19.51 | 16.10 | 19.78 | 20.95 |
Average Receivables |
— | 66.00 | 65.82 | 124.84 | 265.48 | 359.52 | 374.03 | 398.46 | 389.46 |
Average Payables |
35.53 | 42.81 | 94.14 | 178.47 | 306.30 | 347.94 | 364.75 | 414.99 | 495.84 |
Average Inventory |
— | 10.50 | 10.46 | 36.01 | 90.94 | 125.42 | 120.70 | 126.74 | 145.54 |
Average Assets |
186.50 | 184.63 | 457.75 | 1,180.01 | 3,531.98 | 5,235.04 | 4,864.12 | 4,497.80 | 4,401.76 |
Average Common Equity |
50.00 | 51.40 | 32.31 | 121.35 | 1,173.77 | 2,112.22 | 1,812.21 | 1,522.39 | 1,552.22 |
Columns are period end dates